Published Date : 07 Feb 20 | Views: 160 | Industry : Life Science
to Swallow Characteristic of Capsules to Augment the Growth of the Capsule
By application is the key segment of the
global ibuprofen market which is segmented into Suspension, Capsule, Tablet,
and Others. The growing geriatric population suffering from various health
issues such as arthritis, cancer, and back pain find easy to swallow capsules
over tablets. This particular factor is propelling the growth of the capsule
segment. Based on the product, the market is segmented
into EP and USP.
Region is likely to Emerge as the Fastest Growing Region of the Market
Asia-Pacific region is likely to emerge as the fastest-growing region of the
market due to the presence of a large number of patients suffering from chronic
illnesses such as cancer, arthritis, and trauma. Robust growth in the healthcare
sector along with growing awareness regarding health is expected to foster the
growth of the market.
Companies are Keen to Develop New Facilities
of the leading companies profiled in the report are IOLCP, Xinhua
Pharmaceutical, Strides Shasun, Granules Biocause, SI Group, BASF, Xinhua,
Hisoa, and Perrigo Pharmaceutical. Market players are involved in developing
production facilities and announcing collaboration and agreements along with
strengthening the distribution network.
instance, in 2018, Shandong Xinhua Pharmaceutical purchased three ibuprofen
Abbreviated New drug applications in the U.S. from AiPing Pharmaceutical, Inc.
and agreed to grant distribution right to Aiping in the U.S.
Demand for Ibuprofen for the Treatment of Fever and Inflammation to Drive the
Growth of the Market
The basic function of Ibuprofen is to reduce inflammation and fever. The growing prevalence of diseases such as arthritis, cancer, back pain, and the growing mental health conditions such as trauma has resulted in high demand for Ibuprofen. Ibuprofen is a Non-opioids drug that is available at an affordable price and offers a better alternative to opioid pain-killers.